BACKGROUND AND OBJECTIVES: Transoral robotic surgery (TORS) has increased for treatment of oropharyngeal squamous cell carcinoma (OPSCC). To define the adoption of TORS, we analyzed patterns of surgical treatment for OPSCC in the US. METHODS: Cases of T1-T3 OPSCC treated with surgery between 2010 and 2013 from the National Cancer Database were queried. RESULTS: Of 3,071 patients who underwent primary surgical management for T1-T3 OPSCC, 846 (28%) underwent TORS. On multivariable analysis, low tumor stage (T2 vs. T1: OR 0.75, CI 0.37-0.51, P < 0.0001; T3 vs. T1: O.R. 0.33, CI 0.28-0.38, P < 0.0001), treatment at an academic cancer center (O.R. 2.23, C.I. 1.29-3.88, P = 0.004) and treatment at a high volume hospital (34-155 cases vs. 1-4 cases: O.R. 9.07, C.I. 3.19-25.79, P < 0.0001) were associated with increased TORS approach. Significant geographic variation was observed, with high adoption in the Middle Atlantic. Positive margin rates were lower when TORS was performed at a high volume versus low volume hospital (8.2% vs. 16.7% respectively, P = 0.001). CONCLUSIONS: Tumor and non-tumor factors are associated with TORS adoption. This analysis suggests uneven diffusion of this technology in the treatment of OPSCC. J. Surg. Oncol. 2016;114:405-411.
BACKGROUND AND OBJECTIVES: Transoral robotic surgery (TORS) has increased for treatment of oropharyngeal squamous cell carcinoma (OPSCC). To define the adoption of TORS, we analyzed patterns of surgical treatment for OPSCC in the US. METHODS: Cases of T1-T3 OPSCC treated with surgery between 2010 and 2013 from the National Cancer Database were queried. RESULTS: Of 3,071 patients who underwent primary surgical management for T1-T3 OPSCC, 846 (28%) underwent TORS. On multivariable analysis, low tumor stage (T2 vs. T1: OR 0.75, CI 0.37-0.51, P < 0.0001; T3 vs. T1: O.R. 0.33, CI 0.28-0.38, P < 0.0001), treatment at an academic cancer center (O.R. 2.23, C.I. 1.29-3.88, P = 0.004) and treatment at a high volume hospital (34-155 cases vs. 1-4 cases: O.R. 9.07, C.I. 3.19-25.79, P < 0.0001) were associated with increased TORS approach. Significant geographic variation was observed, with high adoption in the Middle Atlantic. Positive margin rates were lower when TORS was performed at a high volume versus low volume hospital (8.2% vs. 16.7% respectively, P = 0.001). CONCLUSIONS:Tumor and non-tumor factors are associated with TORS adoption. This analysis suggests uneven diffusion of this technology in the treatment of OPSCC. J. Surg. Oncol. 2016;114:405-411.
Authors: G Calais; M Alfonsi; E Bardet; C Sire; T Germain; P Bergerot; B Rhein; J Tortochaux; P Oudinot; P Bertrand Journal: J Natl Cancer Inst Date: 1999-12-15 Impact factor: 13.506
Authors: Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison Journal: J Natl Cancer Inst Date: 2008-02-12 Impact factor: 13.506
Authors: Andy Trotti; Thomas F Pajak; Clement K Gwede; Rebecca Paulus; Jay Cooper; Arlene Forastiere; John A Ridge; Deborah Watkins-Bruner; Adam S Garden; K Kian Ang; Wally Curran Journal: Lancet Oncol Date: 2007-07 Impact factor: 41.316
Authors: Michael J Persky; William G Albergotti; Tanya J Rath; Mark W Kubik; Shira Abberbock; Mathew Geltzeiler; Seungwon Kim; Umamaheswar Duvvuri; Robert L Ferris Journal: Otolaryngol Head Neck Surg Date: 2017-11-28 Impact factor: 3.497
Authors: Vishal R Dhere; Chase E Escott; Sibo Tian; Jeffrey M Switchenko; James P Bell; William A Stokes; Mark W McDonald; Kelly R Magliocca; Brian J Boyce; Azeem S Kaka; Conor E Steuer; Nabil F Saba; Dong M Shin; Canhua Xiao; Mihir R Patel; Jonathan J Beitler Journal: Head Neck Date: 2021-12-01 Impact factor: 3.147
Authors: Jamie R Oliver; Michael J Persky; Binhuan Wang; Umamaheswar Duvvuri; Neil D Gross; Alec E Vaezi; Luc G T Morris; Babak Givi Journal: Cancer Date: 2021-11-11 Impact factor: 6.921
Authors: Anthony T Nguyen; Michael Luu; Jon Mallen-St Clair; Alain C Mita; Kevin S Scher; Diana J Lu; Stephen L Shiao; Allen S Ho; Zachary S Zumsteg Journal: JAMA Oncol Date: 2020-10-01 Impact factor: 31.777
Authors: Barry G Main; Natalie S Blencowe; Noah Howes; Sian Cousins; Kerry N L Avery; Alexander Gormley; Phil Radford; Daisy Elliott; Benjamin Byrne; Nicholas Wilson; Robert Hinchliffe; Jane M Blazeby Journal: BMJ Open Date: 2018-01-23 Impact factor: 2.692
Authors: Vincent L Biron; Daniel A O'Connell; Brittany Barber; Jessica M Clark; Colin Andrews; Caroline C Jeffery; David W J Côté; Jeffrey Harris; Hadi Seikaly Journal: J Otolaryngol Head Neck Surg Date: 2017-03-14
Authors: R Michael Baskin; Brian J Boyce; Robert Amdur; William M Mendenhall; Kathryn Hitchcock; Natalie Silver; Peter T Dziegielewski Journal: Cancer Manag Res Date: 2018-04-20 Impact factor: 3.989